Science Explorer Back to mapMap
Discussion
Researcher · Moderna Therapeutics (United States) · United States

Tal Z. Zaks

Tal Z. Zaks publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses and HER2/EGFR in Cancer Research.

OpenAlex
World rank
#177,317
of 7,710,434 ranked researchers
Rank in United States
#66,231
of 1,627,098
Works
100
Citations
11k
Citations per work
114.7
h-index
32
i10-index 49Top 10% in Oncology
Tal Z. Zaks

What does Tal Z. Zaks research?

Tal Z. Zaks's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (12%).

Health Sciences: 43 works · 43.4% of their workMedicine: 43 works · 43.4% of their workOncology: 22 works · 22.0% of their workPulmonary and Respiratory Medicine: 15 works · 15.4% of their workInfectious Diseases: 6 works · 6.0% of their workEverything else: 29 works · 28.6% of their workLife Sciences: 28 works · 28.0% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 16.5% of their workMolecular Biology: 10 works · 9.9% of their workCancer Research: 7 works · 6.6% of their workImmunology and Microbiology: 12 works · 11.5% of their workImmunology: 12 works · 11.5% of their workTHEIR WORKTal Z. Zaks100works
Life Sciences28%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4343.4%
  2. Everything else2928.6%
    1. Biochemistry, Genetics and Molecular Biology1616.5%
    2. Immunology and Microbiology1211.5%
  1. 1Oncology22% of their works
  2. 2Pulmonary and Respiratory Medicine15% of their works
  3. 3Immunology12% of their works
  4. 4Molecular Biology10% of their works
  5. 5Cancer Research7% of their works
  6. 6Infectious Diseases6% of their works

Research topics

Which keywords describe Tal Z. Zaks's research?

The keywords of their largest research topics: Targeted Therapy, Breast Cancer, Cancer Immunotherapy, ALK Inhibitors, EGFR Mutations, Dendritic Cells, Immunity and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy242 topics
  2. Breast Cancer202 topics
  3. Cancer Immunotherapy202 topics
  4. ALK Inhibitors151 topic
  5. EGFR Mutations151 topic
  6. Dendritic Cells131 topic
  7. Immunity131 topic
  8. HER2121 topic
  9. Trastuzumab121 topic
  10. Cancer Genomics91 topic
  11. Mutational Signatures91 topic
  12. CDK4/6 Inhibitors81 topic
  13. Immune Checkpoint Blockade81 topic
  14. PD-1 and PD-L181 topic
  15. Palbociclib81 topic
  16. CAR T Cells71 topic
  17. Chimeric Antigen Receptor71 topic
  18. RNA Interference51 topic
  19. siRNA Delivery51 topic

Where does Tal Z. Zaks work?

Tal Z. Zaks's main affiliation in the publication record is Moderna Therapeutics (United States), United States.

How many publications and citations does Tal Z. Zaks have?

OpenAlex counts 100 works and 11,474 citations for Tal Z. Zaks, an h-index of 32, ranking #177,317 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tal Z. Zaks. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.